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Abstract
Pseudomonas aeruginosa genotyping relies mainly upon DNA ﬁngerprinting methods, which can be subjective, expensive and time-con-
suming. The detection of at least three different clonal P. aeruginosa strains in patients attending two cystic ﬁbrosis (CF) centres in a sin-
gle Australian city prompted the design of a non-gel-based PCR method to enable clinical microbiology laboratories to readily identify
these clonal strains. We designed a detection method utilizing heat-denatured P. aeruginosa isolates and a ten-single-nucleotide polymor-
phism (SNP) proﬁle. Strain differences were detected by SYBR Green-based real-time PCR and high-resolution melting curve analysis
(HRM10SNP assay). Overall, 106 P. aeruginosa sputum isolates collected from 74 patients with CF, as well as ﬁve reference strains, were
analysed with the HRM10SNP assay, and the results were compared with those obtained by pulsed-ﬁeld gel electrophoresis (PFGE).
The HRM10SNP assay accurately identiﬁed all 45 isolates as members of one of the three major clonal strains characterized by PFGE in
two Brisbane CF centres (Australian epidemic strain-1, Australian epidemic strain-2 and P42) from 61 other P. aeruginosa strains from
Australian CF patients and two representative overseas epidemic strain isolates. The HRM10SNP method is simple, is relatively inexpen-
sive and can be completed in <3 h. In our setting, it could be made easily available for clinical microbiology laboratories to screen for
local P. aeruginosa strains and to guide infection control policies. Further studies are needed to determine whether the HRM10SNP
assay can also be modiﬁed to detect additional clonal strains that are prevalent in other CF centres.
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Introduction
Cystic ﬁbrosis (CF) is a multisystem disorder, and chronic
pulmonary infection accounts for most CF-related deaths
[1]. Pseudomonas aeruginosa is the dominant pathogen, and its
acquisition leads to increased morbidity [2,3]. Patients usually
acquire their own unique P. aeruginosa strains from the
environment. However, molecular-based typing tests have
detected indistinguishable clonal strains in unrelated patients
[4–6], and given the reduced incidence of these strains
following strict patient segregation, this suggests that cross-
infection is also important [7]. As compared with unique
strains, some clonal strains have also been associated with
worse clinical outcomes [5–8]. As part of an overall strategy
for delaying P. aeruginosa infection in CF patients, clinical
microbiology laboratories need simple and inexpensive typing
methods to detect clonal strains and guide infection control
strategies.
With its high discriminatory power, pulsed-ﬁeld gel elec-
trophoresis (PFGE) is considered to be the reference stan-
dard for molecular typing. However, it is laborious and takes
‡3 days to complete. PFGE interpretation relies upon gel
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electrophoresis banding patterns, which can be subjective,
particularly when different test runs are compared [9]. An
alternative typing method is repetitive-element PCR (Rep-
PCR) [10]. Rep-PCR can be completed within 10 h, but it is
also gel-based and suffers from the same interpretative limi-
tations. Alternatively, multilocus sequence typing (MLST)
identiﬁes allelic differences between highly conserved house-
keeping genes. Although it is objective and extremely robust,
MLST is expensive, requires specialized equipment and takes
several days to perform. It is better suited for determining
genetic relatedness than differences, and is not as discrimina-
tory as PFGE as a molecular surveillance tool [11].
In contrast, high-resolution melting (HRM) curve analysis
recognizes the precise melting curve shape of ampliﬁed dou-
ble-stranded DNA, which itself is determined by DNA
sequences. HRM analyses differences in melting temperature
to <0.1C, and can detect single-nucleotide polymorphisms
(SNPs) in small PCR products [12]. The platforms are single
step and closed tube, enabling rapid testing, and ‘black box’
analysis and software facilitate objective result interpretation.
HRM has been used to successfully type different bacterial
pathogens [13,14]. We developed an SNP-based HRM assay
(HRM10SNP assay) to identify the major clonal P. aeruginosa
strains (Australian epidemic strain-1 (AES-1), Australian epi-
demic strain-2 (AES-2) and pulsotype P42) present in several
patients attending paediatric and adult CF centres in Bris-
bane, Australia [6].
Materials and methods
P. aeruginosa isolates
As part of a national P. aeruginosa prevalence study in Aus-
tralian CF centres, 106 isolates were selected from the
sputum of 74 CF patients, 32 of whom provided a second
specimen 6 months later [15]. These included 45 isolates
previously characterized by Rep-PCR as AES-1, AES-2 or
P42 [10]. The remaining 61 isolates were selected randomly
from isolates that had undergone Rep-PCR typing and did
not align with the above clonal strains. Overall, 55 isolates
were from Queensland, and the remaining 51 were from
other Australian states. All isolates were conﬁrmed as
P. aeruginosa by a duplex real-time PCR assay [16]. Repre-
sentatives of the Liverpool (LES) and Manchester (MAN)
epidemic strains were included, as were the P3, P5 and
P58 minor clones. The latter strains are present in small
numbers of patients managed at two paediatric and adult
CF centres in Brisbane [6]. To assess reproducibility, con-
ﬁrmed AES-1, AES-2 and P42 isolates were incorporated
into each run.
PFGE
PFGE was performed on all isolates [17]. Brieﬂy, DNA was
prepared with the GenePath Group 3 Reagent kit (Bio-Rad
Laboratories, Gladesville, NSW, Australia), according to the
manufacturer’s instructions. Macrorestriction digestion of
each DNA sample was performed with the SpeI enzyme.
PFGE banding patterns were assessed for relatedness by the
Tenover criteria [18] and FPQuest cluster analysis software
version 4.5 (Bio-Rad Laboratories). Percentage similarity of
the banding patterns was estimated with the Dice coefﬁcient,
and the matrix of similarity coefﬁcients was clustered by the
unweighted pair group method with arithmetic mean. Iso-
lates exhibiting PFGE patterns that differed by six or fewer
bands and were ‡80% related by cluster analysis were cate-
gorized as the same strain.
HRM curve-based SNP typing proﬁle assay
To design the HRM10SNP assay, we performed DNA
sequencing of the seven MLST housekeeping genes [19] for
ten P. aeruginosa isolates, including one isolate each of AES-1,
AES-2 and P42, ATCC strain 27853 and six randomly
selected unique strains from Brisbane CF patients. The
sequence data were investigated for SNPs that would enable
discrimination of the three major clonal strains from one
another and all other strains. Twenty candidate SNPs were
chosen initially (Table 1). The 106 isolates and ﬁve reference
strains were then tested by HRM curve analysis for all 20
SNPs (HRM20SNP). These data were used to select a ten-
SNP proﬁle (HRM10SNP) for further testing.
Bacterial DNA was released by a basic heat-treatment
method and stored at )20C until testing [20]. Primers
were designed to ﬂank the 20 SNPs of interest. The 40
oligonucleotides designed and the alleles targeted are pre-
sented in Table 1. HRM curve reactions were performed
with a standard reaction mix and previously described
cycling conditions [20]. Each reaction mix contained 10.0 lL
of 2 · SYBR green qPCR SuperMix-UDG (Invitrogen Aus-
tralia, Mulgrave, NSW, Australia), 0.5 lM forward and
reverse primers, 1.0 lL of heat-denatured isolate and
DNase-free water to a total volume of 20.0 lL. Cycling was
performed on a RotorGene 6000 (Qiagen, Doncaster, Aus-
tralia) with the following cycling conditions: an initial hold of
2 min at 50C, an enzyme activation step at 95C for
2 min, 40 cycles of denaturation at 95C for 10 s, and
primer annealing and elongation at 60C for 30 s, with the
ﬂuorescence signal being read on green at 60C following
extension. HRM curve analysis was performed following
PCR ampliﬁcation; reaction mixes were analysed continu-
ously from 60C to 95C, with temperature increments of
0.5C/s. HRM curve result analysis was performed with the
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Rotor-Gene 6000 HRM software (Qiagen) with a conﬁdence
setting of 90%.
Statistical analysis
Discriminatory power and assay concordance were calcu-
lated with EpiCompare v1.0 (Ridom GmbH, Wurzburg, Ger-
many) software. Discriminatory indices were determined for
individual SNPs, PFGE, the HRM20SNP assay and the
HRM10SNP assay, by use of Simpson’s index of diversity
[21,22]. The adjusted Rand index provided a quantitative
measure of assay congruence, and the Wallace coefﬁcient
was used to assess the levels of bi-directional correspon-
dence between each typing strategy [23,24].
Results
Table 2 summarizes the PFGE and SNP HRM curve assay
(HRM20SNP and HRM10SNP) results. Overall, PFGE charac-
terized the 106 sputum P. aeruginosa isolates into 35 distinct
pulsotypes.
With the HRM20SNP proﬁle, AES-1, AES-2 and P42 clonal
strains were distinguishable from each other and from all
other PFGE pulsotypes, with 55 different ‘HRM20SNP’ pro-
ﬁles being seen (Table 2). At least nine of these proﬁles
were from variations, where the HRM curve method failed
to identify the SNP present. For example, in Table 2, SNP 9
of the HRM20SNP proﬁle for an AES-1 isolate could not be
identiﬁed. Similar variations were observed for this and
other SNPs across AES-2, P42 and other PFGE pulsotypes
(Table 2). Additionally, pulsotypes 58 and 14, and 12 and 32,
could not be discriminated by the HRM20SNP proﬁle.
From the 20-SNP data, ten SNPs from ﬁve housekeeping
genes (Table 1) were selected for the HRM10SNP assay, as
they: (i) could identify and discriminate between each of the
three highly prevalent clonal strains in Brisbane CF centres
by at least two SNPs; (ii) were conserved within each of the
three clonal strains; and (iii) provided minimal variation
TABLE 1. Oligonucleotides used for single-nucleotide polymorphism (SNP) high-resolution melting (HRM) curve analysis in
the HRM10SNP assay
SNP Gene Primer name Primer position Primer sequence (5¢–3¢)
SNP
position
Ten
SNP
Discriminatory
power (95% CI)
1 acsA acsA-970630-F 970 609–970 629 ACCTACATCGTCTATGGCCCG T970630Ca Yes 0.504 (0.501–0.508)
acsA-970630-R 970 631–970 644 GGCGCCGTTGGCCA
2 acsA acsA-970945-F 970 928–970 944 CCTGCCTGATGACCCCG T970945Ca Yes 0.546 (0.488–0.604)
acsA-970945-R 970 946–970 958 TGGGCGCCCGGCA
3 acsA acsA-970977-F 970 960–970 976 GCGATGAAGCCGGGCTC T970977Ca Yes 0.528 (0.495–0.561)
acsA-970977-R 970 978–970 995 GAAGAACGGCTTGGCTGC
4 acsA acsA-971022-F 971 003–971 021 TACCGGCACTGGTGGACAA C971022Ta Yes 0.418 (0.340–0.496)
acsA-971022-R 971 023–971 041 CCTCGATCAGGTTGCCGAG
5 aroE aroE-26908-F 26 889–26 907 CCGTGCCGTTCAAGGAAGA G26908Aa 0.568 (0.483–0.652)
aroE-26908-R 26 909–26 928 TCGTCCACCAGACGATAGGC
6 aroE aroE-26929-F 26 909–26 928 GCCTATCGTCTGGTGGACGA G26929Aa 0.357 (0.262–0.451)
aroE-26929-R 26 930–26 945 TGGCCCGCTCGCTCAA
7 guaA guaA-1304174-F 1 304 159–1 304 173 GTGGTCGCCGCGCTG C1304174Tb 0.199 (0.105–0.293)
guaA-1304174-R 1304175–1304191 GCCGATGGCCTTGTGCA
8 guaA guaA-1304389-F 1 304 370–1 304 388 GCCGCACCTTCATCGAAGT T1304389Cb Yes 0.498 (0.449–0.547)
guaA-1304389-R 1 304 390–1 304 409 TTGGTGGCTTCTTCGTCGAA
9 mutL mutL-5551075-F 5 551 059–5 551 074 GGCAAGACCATCTTCGCC C5551075Ta 0.263 (0.159–0.367)
mutL-5551075-R 5 551 076–5 551 071 TCTCGCGCCTCGTGCA
10 mutL mutL-5551184-F 5 551 167–5 551 183 CGGCGCAAGTTCCTGCG T5551184Ca 0.519 (0.477–0.561)
mutL-5551184-R 5 551 185–5 551 204 TCGAACTCGGTCTTCTCGGC
11 nuoD nuoD-2984529-F 2 984 509–2 984 528 AAGCAGGACCTGGAGCAGGA A2984529Ga 0.513 (0.450–0.575)
nuoD-2984529-R 2 984 530–2 984 546 GGCTTGAAGCGCAGGGC
12 nuoD nuoD-2984751-F 2 984 730–2 984 750 CCAGTCCTGGCACAGTTTCAT C2984751Ta 0.404 (0.311–0.497)
nuoD-2984751-R 2 984 752–2 984 769 GATGCGGTCGGTGTAGGG
13 nuoD nuoD-2984829-F 2 984 810–2 984 828 TCTCGGTGGAGAAGCTCGC C2984829Aa 0.072 (0.005–0.139)
nuoD-2984829-R 2 984 830–2 984 848 CTGGGGCACCTTGATCCC
14 nuoD nuoD-2985042-F 2 985 025–2 985 041 GCCTGGTACCGCATCGG C2985042Ta Yes 0.141 (0.052–0.230)
nuoD-2985042-R 2 985 043–2 985 057 GTCGTGGGCGACGCC
15 ppsA ppsA-1915236-F 1 915 219–1 915 235 GACCCGGACTGGGAGCC G1915236Aa Yes 0.421 (0.349–0.493)
ppsA-1915236-R 1 915 237–1 915 253 CTGGCGCGCTTCATCAC
16 ppsA ppsA-1915314-F 1 915 295–1 915 313 CGATCATCGCTCGCGAACT G1915314Aa Yes 0.185 (0.092–0.277)
ppsA-1915314-R 1 915 315–1 915 329 CACCGCCGGGATGCC
17 ppsA ppsA-1915596-F 1 915 579–1 915 595 CGCATGATCGGCGTGCA C1915596Ta Yes 0.507 (0.442–0.571)
ppsA-1915596-R 1 915 597–1 915 617 AAGTTCAGCAATGCCTTGGG
18 ppsA ppsA-1915701-F 1 915 680–1 915 700 GGTCGGCTTCTACGTCGAGAA G1915701Aa 0.055 (0.000–0.115)
ppsA-1915701-R 1 915 702–1 715 720 TGCTGATGCCCTCCACCAG
19 trpE trpE-671942-F 671 924–671 941 CGAAGAGGCCGACCTGGC A671942Ga Yes 0.482 (0.432–0.532)
trpE-671942-R 671 943–671 961 ACAGCAGATCCTGCTCCAG
20 trpE trpE-672254-F 672 235–672 253 AGCGTGGAGTCTACGGCGG C672254Ta 0.09 (0.015–0.164)
trpE-672254-R 672 255–672 271 GCCAGGTAGCCGACCGC
F, forward; R, Rreverse.
aGenbank accession number AE004091.2
bGenbank accession number PALESB58-FM209186.
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across all isolates. The SNPs chosen for the HRM10SNP
assay are listed in Table 1, and the results given in Table 2.
The HRM10SNP assay was able to consistently discriminate
the three major clonal P. aeruginosa strains from one another
and from other unique and minor clonal strains identiﬁed by
PFGE from the sample collection.
Discriminatory indices for the individual SNPs ranged from
0.055 to 0.568 (Table 1). Eight of the 12 SNPs with discrimi-
natory indices exceeding 0.4 were incorporated in the
HRM10SNP assay. Table 3 shows the discriminatory power
and levels of agreement calculated for PFGE, HRM20SNP
and HRM10SNP typing. The HRM20SNP assay had the high-
est discriminatory power (0.941), and the HRM10SNP assay
was equivalent to PFGE (0.921). The highest level of assay
concordance (adjusted Rand = 0.973) and bi-directional cor-
respondence (Wallace coefﬁcient: 0.974–0.976) were
observed between the HRM10SNP assay and PFGE. How-
ever, both PFGE and the HRM10SNP assay were poorer
predictors of HRM20SNP type than the HRM20SNP assay
was of PFGE and HRM10SNP types.
TABLE 2. Results of pulsed-ﬁeld gel
electrophoresis (PFGE) and single-
nucleotide polymorphism (SNP)
high-resolution melting (HRM)
curve assays (dots indicate match
with AES-1 reference sequence)
No. of isolates
n = 108a
PFGE
pulsotype
HRM20SNP proﬁle
(SNPs 1–20)
HRM10SNP: ten-SNP
proﬁle (SNPs 1, 2, 3, 4,
8, 14–17 and 19)
19 AES-1 CTCCAgCTCTACCCgGCGAC CTCCTCgGCA
1 AES-1 ........v........... ..........
17 AES-2 TCTTg....C......T... TCTT....T.
1 AES-2 TCTTg....CgT....TA.. TCTT....T.
1 AES-2 TCTTg....C......TA.. TCTT....T.
1 AES-2 TCTTg...vC......T... TCTT....T.
1 AES-2 TCTTg....v......T... TCTT....T.
1 P42 .CT..ATC....AT.AT.gT .CT.CT.Atg
3 P42 .CT.vATC....AT.AT.gT .CT.CT.Atg
2 P13 .C..g..C......A.T... .C..C.A.T.
1 P20 .C..g..C...T......g. .C..C....g
1 P20 .C..g.TC...T......g. .C..C....g
1 P5 (minor clone) .CT.g.TC......A.T... .CT.C.A.T.
4 P11 .CT.gA.C.Cg...A.T.g. .CT.C.A.Tg
1 P11 .CT.gA.C.Cv...A.T.g. .CT.C.A.Tg
1 P34 .CT.gA.C..g.....T.g. .CT.C...Tg
2 P3 (minor clone) .CT.gA....gT..A.T.g. .CT...A.Tg
1 P3 (minor clone) .Cv.gA....vT..A.T.g. .Cv...A.Tg
2 P14 .CT.g............... .CT.......
1 P58 (minor clone) .CT.g............... .CT.......
1 P58 (minor clone) .CT.g.....gT......g. .CT......g
1 P30 .CT.g......T.T..T.g. .CT..T..Tg
1 P31 .CT.g......T.v..T.g. .CT..v..Tg
1 P29 .Cv.g...v.gT...AT.g. .Cv....Atg
2 P23 ....g..C.C....A.T.g. ....C.A.Tg
1 P22 ....gATC.C........g. ....C....g
1 P22 ....gA.C.Cvv....v.gv ....C...vg
1 P24 ....g.TC..........g. ....C....g
1 P27 ....g.........A.T.g. ......A.Tg
1 P21 .v..gA.CvCg...A.T.g. .v..C.A.Tg
1 P21 .v..gA.CvCgv..A.v.g. .v..C.A.vg
2 P17 .vT.gA.CvCgT..A.T.g. .vT.C.A.Tg
1 P26 TC..g.TC......A.T... TC..C.A.T.
1 P9 TC..gvTCv.....A.T... TC..C.A.T.
1 P9 TC..g.TCv.....A.T... TC..C.A.T.
1 P9 TC..g.TCv.....A.Tv.. TC..C.A.T.
1 P28 TC..g..C..gT..A.T... TC..C.A.T.
2 P7 TC..g...T.gT........ TC........
1 P7 TC.vg...T.gT........ TC.v......
1 P16 TC.Tg..C.C........g. TC.TC....g
1 P16 Tv.Tg..C.C.v....v.g. Tv.TC...vg
1 P4 TC.Tv..vv.gv..A.v... TC.Tv.A.v.
2 P12 TCTTg..C..gT..A.T... TCTTC.A.T.
1 P12 TCvTg..C..gT..A.T... TCvTC.A.T.
1 P32 TCTTg..C..gT..A.T... TCTTC.A.T.
1 P8 TCTTg..C.CgT..A.T.g. TCTTC.A.Tg
1 MAN TCTTg.........A.T.g. TCTT..A.Tg
1 P25 T...g..C.C.......... T...C.....
1 P33 T...g..C.CgT......v. T...C....v
1 P18 T...g..CTCg..v..T.g. T...Cv..Tg
1 P18 Tv..gv.vvCg..v..v.g. Tv..vv..vg
2 P15 T...g.....gT..A.T.g. T.....A.Tg
5 P10 T...g....Cg....AT... T......AT.
1 P10 T...g....vg....AT... T......AT.
1 LES T.T.g...........T.g. T.T.....Tg
1 P19 Tv..gA.C.vg.......g. Tv..C....g
1 P19 Tv..gA.C.Cg.......g. Tv..C....g
v, variation.
The HRM method failed to identify the SNP present.
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Discussion
By targeting ten key SNPs identiﬁed in ﬁve housekeeping
genes, the HRM10SNP assay was as discriminatory as PFGE
in distinguishing AES-1, AES-2 and P42 from one another and
the 32 other unrelated P. aeruginosa strains detected in Aus-
tralian CF patients. The assay has several advantages over
other genotyping methods. The incorporation of a simple
heat-denaturation step for isolate preparation avoided the
need for often expensive and time-consuming commercial
DNA extraction kits. At AUD$2 (€1.40) per HRM curve
reaction, the HRM10SNP method was performed within 3 h
for AUD$20 (€14.22). Use of the HRM software for SNP
identiﬁcation also increased objectivity as compared with gel-
based methods. A limitation was that several SNPs could not
be identiﬁed. This was not investigated further, but probably
resulted from sequence variations within assay targets [20].
Notably, these variations did not alter AES-1, AES-2 and P42
detection by either the HRM20SNP or HRM10SNP proﬁles,
given that these strains differed by at least two SNPs from
every other PFGE pulsotype. Should the HRM assay be
adapted to detect other clonal strains, the impact of these
variations will require further investigation.
The HRM10SNP method was developed speciﬁcally to
detect AES-1, AES-2 and P42 strains. PFGE remains the ref-
erence standard for P. aeruginosa typing, and this is high-
lighted in our study by several PFGE pulsotypes being
indistinguishable by either their HRM20SNP or HRM10SNP
proﬁle. Despite this, we found that the discriminatory pow-
ers of PFGE, the HRM20SNP assay and the HRM10SNP
assay were largely equivalent. Using an adjusted Rand index
and the Wallace coefﬁcient, we also found that HRM10SNP
type was highly indicative of PFGE type, and PFGE type was
suggestive of HRM10SNP type. In contrast, both HRM10SNP
and PFGE results were less concordant with HRM20SNP
results. This lack of bi-directional correspondence may result
from the additional SNP variations that we observed in the
HRM20SNP assay or, alternatively, could reﬂect enhanced
discrimination between isolates through the inclusion of addi-
tional informative SNPs.
Even though the HRM10SNP assay could distinguish the
LES and MAN strains from local isolates, given the epidemio-
logical and genetic diversity of P. aeruginosa, further studies
are needed to assess the HRM10SNP assay’s role in other
CF centres. Nevertheless, the ease with which the method
was developed shows that it could be readily adapted for
other strains by limited housekeeping gene DNA sequencing
and HRM screening of additional SNPs.
In conclusion, the HRM10SNP assay is a fast, simple, accu-
rate and inexpensive method for identifying common clonal
P. aeruginosa strains in Brisbane CF patients. In our setting, it
could be made easily available to clinical microbiology labora-
tories as a surveillance tool for informing CF infection con-
trol policies.
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